|Last Price$9.50||Day Change (%)-0.01%|
|Open Price$9.50||Day Change ($)0.00|
|Day Range9.50–9.50||52-Week Range9.04–9.61|
As of Mon 10/24/2016 | USD
Maxygen MAXY announced that its partner Roche RHHBY placed a hold on development of Maxy -Alpha--the first of Maxygen's shuffled proteins to enter clinical development--and we're lowering our fair value estimate accordingly. While we had only placed a 20% probability on the eventual approval of ...
Early data from Maxygen's pipeline is encouraging, but key trials are just beginning.
Maxygen's pipeline is entering the clinic, but its technology remains unproven.